Ampersand Capital Partners

Founded in 1988, Ampersand Capital Partners is a middle-market private equity firm with $3 billion of assets under management, dedicated to growth-oriented investments in the healthcare sector. Ampersand invests in companies that support the life sciences ecosystem, including laboratory products & services, contract manufacturing, pharma services and specialty pharma. With offices in Boston, MA, Amsterdam, Netherlands, and London, UK, Ampersand leverages a unique blend of private equity and operating experience to build value and drive long-term performance alongside its portfolio company management teams.